INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,143,195 | -18.6% | 167,103 | +8.0% | 0.00% | – |
| Q2 2023 | $1,404,494 | +51.3% | 154,680 | +7.7% | 0.00% | – |
| Q1 2023 | $928,024 | +102330.9% | 143,657 | +0.5% | 0.00% | – |
| Q4 2022 | $906 | -99.9% | 142,997 | +2.4% | 0.00% | – |
| Q3 2022 | $865,000 | -29.2% | 139,606 | +1.0% | 0.00% | – |
| Q2 2022 | $1,221,000 | +13.8% | 138,224 | +8.4% | 0.00% | – |
| Q1 2022 | $1,073,000 | -11.0% | 127,529 | +7.8% | 0.00% | – |
| Q4 2021 | $1,206,000 | -30.7% | 118,270 | +32.0% | 0.00% | – |
| Q3 2021 | $1,740,000 | +34.3% | 89,607 | +21.4% | 0.00% | – |
| Q2 2021 | $1,296,000 | +79.5% | 73,794 | +21.3% | 0.00% | – |
| Q1 2021 | $722,000 | +24.7% | 60,837 | +80.8% | 0.00% | – |
| Q4 2020 | $579,000 | +87.4% | 33,655 | +12.1% | 0.00% | – |
| Q3 2020 | $309,000 | – | 30,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
| Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
| DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
| YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
| Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
| Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
| Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
| Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
| FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |